CA2447564A1 - Nucleic acids and corresponding proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer - Google Patents

Nucleic acids and corresponding proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer Download PDF

Info

Publication number
CA2447564A1
CA2447564A1 CA002447564A CA2447564A CA2447564A1 CA 2447564 A1 CA2447564 A1 CA 2447564A1 CA 002447564 A CA002447564 A CA 002447564A CA 2447564 A CA2447564 A CA 2447564A CA 2447564 A1 CA2447564 A1 CA 2447564A1
Authority
CA
Canada
Prior art keywords
protein
1o1p3a11
antibody
cells
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002447564A
Other languages
English (en)
French (fr)
Inventor
Aya Jakobovits
Mary Faris
Arthur B. Raitano
Robert Kendall Morrison
Douglas Saffran
Wangmao Ge
Pia M. Challita-Eid
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Agensys Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/001,469 external-priority patent/US7208280B2/en
Priority claimed from US10/017,066 external-priority patent/US6838258B2/en
Application filed by Individual filed Critical Individual
Publication of CA2447564A1 publication Critical patent/CA2447564A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002447564A 2001-05-15 2002-05-15 Nucleic acids and corresponding proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer Abandoned CA2447564A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US29111801P 2001-05-15 2001-05-15
US60/291,118 2001-05-15
US10/001,469 2001-10-31
US10/001,469 US7208280B2 (en) 1999-10-05 2001-10-31 Nucleic acid and corresponding protein entitled 101P3A41 useful in treatment and detection of cancer
US10/017,066 2001-12-14
US10/017,066 US6838258B2 (en) 1999-10-05 2001-12-14 G protein-coupled receptor up-regulated in prostate cancer and uses thereof
PCT/US2002/015520 WO2002092842A2 (en) 2001-05-15 2002-05-15 Nucleic acids and corresponsing proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer

Publications (1)

Publication Number Publication Date
CA2447564A1 true CA2447564A1 (en) 2002-11-21

Family

ID=38616826

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002447564A Abandoned CA2447564A1 (en) 2001-05-15 2002-05-15 Nucleic acids and corresponding proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer

Country Status (6)

Country Link
EP (1) EP1539805A4 (de)
JP (1) JP2005512509A (de)
AU (2) AU2002309873B2 (de)
CA (1) CA2447564A1 (de)
IL (1) IL158860A0 (de)
WO (1) WO2002092842A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7361338B2 (en) 1999-10-05 2008-04-22 Agensys, Inc. Methods to inhibit growth of prostate cancer cells
US6790631B1 (en) 1999-10-05 2004-09-14 Agensys, Inc. G protein-coupled receptor up-regulated in prostate cancer and uses thereof
US7208280B2 (en) 1999-10-05 2007-04-24 Agensys, Inc. Nucleic acid and corresponding protein entitled 101P3A41 useful in treatment and detection of cancer
FI1897548T4 (fi) * 2003-02-28 2024-09-03 The Johns Hopkins University T-solujen säätely
JP5122592B2 (ja) * 2010-01-04 2013-01-16 アジェンシス，インコーポレイテッド 癌の処置および検出において有用な２４ｐ４ｃ１２と称される、核酸および対応タンパク質
US10722563B2 (en) * 2012-09-20 2020-07-28 Shenzhen Innovation Immunotechnology Co., Ltd. Prostate-specific tumor antigens and uses thereof
CN111549140B (zh) * 2020-06-08 2023-08-08 重庆医科大学附属第一医院 一种检测肺癌相关基因C2orf40、FIBIN和GRP甲基化的试剂盒及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0914142B9 (de) * 1996-03-11 2012-01-04 Epimmune Inc. Peptide mit erhöhter bindungsaffinität für mindestens drei hla-a3-ähnliche moleküle
US6800746B2 (en) * 1997-02-25 2004-10-05 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
WO2000020590A2 (en) * 1998-10-06 2000-04-13 Incyte Pharmaceuticals, Inc. G-protein coupled receptor proteins
WO2000044775A2 (en) * 1999-01-27 2000-08-03 Epimmune Inc. Identification of broadly reactive hla restricted t cell epitopes
US7361338B2 (en) * 1999-10-05 2008-04-22 Agensys, Inc. Methods to inhibit growth of prostate cancer cells
IL147952A0 (en) * 1999-10-05 2002-08-14 Agensys Inc G protein-coupled receptor up-regulated in prostate cancer and uses thereof
WO2001027158A2 (en) * 1999-10-08 2001-04-19 Digiscents Olfactory receptor sequences
JP2004504010A (ja) * 2000-03-13 2004-02-12 セノミックス　インコーポレイテッド ヒト嗅覚レセプター及びそれをコードする遺伝子
AU2001249549A1 (en) * 2000-03-27 2001-10-08 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
JP2003534779A (ja) * 2000-03-31 2003-11-25 キュラジェン コーポレイション Ｇタンパク質結合レセプターおよびこのｇタンパク質結合レセプターをコードする核酸
US20030022237A1 (en) * 2000-09-27 2003-01-30 Feder John N. Novel human G-protein coupled receptor, HGPRBMY4, expressed highly in prostate, colon, and lung
WO2002061087A2 (en) * 2000-12-19 2002-08-08 Lifespan Biosciences, Inc. Antigenic peptides, such as for g protein-coupled receptors (gpcrs), antibodies thereto, and systems for identifying such antigenic peptides
US20030108963A1 (en) * 2001-07-25 2003-06-12 Millennium Pharmaceuticals, Inc. Novel genes, compositions, kit, and methods for identification, assessment, prevention and therapy of prostate cancer

Also Published As

Publication number Publication date
AU2008200363B2 (en) 2010-08-12
AU2008200363A1 (en) 2008-02-21
WO2002092842A2 (en) 2002-11-21
EP1539805A4 (de) 2005-11-16
WO2002092842A3 (en) 2005-04-21
AU2008200363A8 (en) 2008-03-13
IL158860A0 (en) 2004-05-12
JP2005512509A (ja) 2005-05-12
AU2002309873B2 (en) 2007-10-18
EP1539805A2 (de) 2005-06-15

Similar Documents

Publication Publication Date Title
US8236510B2 (en) Protein showing enhanced expression in cancer cells
US7928196B2 (en) Nucleic acid and corresponding protein entitled 125P5C8 useful in treatment and detection of cancer
US7982004B2 (en) Nucleic acid and corresponding protein entitled 161P5C5 useful in treatment and detection of cancer
US8003100B2 (en) Antibodies that bind to 238P1B2
AU2008200363B2 (en) Nucleic acids and corresponding proteins entitled 101P3A11 or PHOR-1 useful in treatment and detection of cancer
US8039603B2 (en) Nucleic acid and corresponding protein entitled 121P1F1 useful in treatment and detection of cancer
US7459539B2 (en) Antibody that binds zinc transporter protein 108P5H8
US8173381B2 (en) Nucleic acid and corresponding protein entitled 85P1B3 useful in treatment and detection of cancer
WO2002014361A2 (en) NUCLEIC ACIDS AND CORRESPONDING PROTEINS ENTITLED 83P2H3 AND CaTrF2E11 USEFUL IN TREATMENT AND DETECTION OF CANCER
US20100086985A1 (en) Nucleic acid and corresponding protein entitled 205p1b5 useful in treatment and detection of cancer
AU2002309873A1 (en) Nucleic acids and corresponding proteins entitled 101P3A11 or PHOR-1 useful in treatment and detection of cancer
US8647826B2 (en) Nucleic acid and corresponding protein entitled 125P5C8 useful in treatment and detection of cancer
US20030091562A1 (en) Nucleic acid and corresponding protein entitled 101P3A41 useful in treatment and detection of cancer
WO2002014501A2 (en) Nucleic acids and corresponding proteins entitled phor1-a11 and phor1-f5d6 useful in treatment and detection of cancer
US20030134784A1 (en) Nucleic acids and corresponding proteins entitled 83P2H3 and CaTrF2E11 useful in treatment and detection of cancer
US20120076789A1 (en) Nucleic acid and corresponding protein entitled 121p1f1 useful in treatment and detection of cancer
IL158860A (en) 101p3a11 peptides for use in vaccine preparation

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued